Genetic Technologies (ASX:GTG) said the US patent office has, for a third time, upheld the validity of claims in one of its non-coding DNA patents. [ + ]

Australian scientists and researchers from the Research Alliance have put out a call to policymakers asking for a strategic and stable plan for science and research that will stop the country falling behind the rest of the world. [ + ]

Bioniche (ASX:BNC) has reported its FY13 results and completed a Canadian equity offering and private placement to raise C$9.8m. [ + ]

The Medical Technology Association of Australia Limited has appointed Susanne Tegen as its new chief executive officer. [ + ]

The concept team behind Massey University's multifunction teaching laboratories were awarded the Best Practice Award for Innovation at the Association for Tertiary Education Management conference, recently held in Australia. [ + ]

Researchers at Otago and Heidelberg Universities have discovered how the brain circuitry vital to normal fertility in humans and other mammals operates. Their findings have been published in the international journal Nature Communications. [ + ]

After raising $1m last year, ImmunAid has launched a second funding round to support development of its personalised treatment technology and IP. [ + ]

The Victorian Government has awarded Technology Development vouchers worth up to $50K for 10 high-tech projects, including research into potential treatments for Crohn's disease. [ + ]

An explanation for how a subset of ovarian cancers block the body's early anti-tumour immune response may expand treatment options for patients. [ + ]

An African medicinal plant - Nauclea latifolia (also known as the pin cushion tree) - has been found to produce large quantities of molecules with analgesic properties. Even more surprising, analysis shows that the molecule is identical to the heretofor wholly synthetic painkiller Tramadol. [ + ]

Biotechnology industry experts are joining forces to support a 'patent box' tax incentive, like that recently introduced on the UK, to keep home-grown IP in Australia and keep the local medical manufacturing industry globally competitive. [ + ]

pSivida (ASX:PVA) attributed costs associated with initiating its phase III trial of Medidur in posterior uveitis for a 69% higher Q4 loss. [ + ]

To celebrate and recognise creativity in Australian imaging science research, CiSRA and the Powerhouse Museum have launched the Extreme Imaging Competition for 2014. [ + ]

The link between neurodegenerative diseases and the consumption of food or water contaminated by blue-green algae has been strengthened with research showing how the algal toxin is misincorporated into proteins. [ + ]

iSonea's flagship AirSonea smartphone-compatible asthma wheeze monitoring device was launched in Australia today by gold medallist Cathy Freeman. [ + ]